{"id":"NCT00421343","sponsor":"Hebrew SeniorLife","briefTitle":"Secondary Prevention of Osteoporosis","officialTitle":"Secondary Prevention of Osteoporosis: A Window of Opportunity in the Acute Rehabilitation Setting","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-02","primaryCompletion":"2008-06","completion":"2008-06","firstPosted":"2007-01-12","resultsPosted":"2011-06-10","lastUpdate":"2020-02-05"},"enrollment":29,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Osteoporosis"],"interventions":[{"type":"DRUG","name":"alendronate with cholecalciferol","otherNames":["Fosamax Plus DÂ®"]},{"type":"DRUG","name":"calcium carbonate with cholecalciferol","otherNames":["Os-Cal with extra D"]},{"type":"BEHAVIORAL","name":"Falls prevention measures","otherNames":[]}],"arms":[{"label":"Treatment for osteoporosis and falls","type":"OTHER"}],"summary":"The purpose of this study is to develop and implement an evidence based protocol for the secondary prevention of osteoporotic fractures and falls, and to determine how compliance with this intervention improves muscle strength and functional status following a fracture.","primaryOutcome":{"measure":"Number Adherent With the Intervention","timeFrame":"6 months","effectByArm":[{"arm":"Osteoporosis Medication","deltaMin":29,"sd":null}],"pValues":[]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["16357705","9278463","9875874","14583918","14557214"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":29},"commonTop":[]}}